Kubota Pharmaceutical Holdings Co., Ltd. Logo

Kubota Pharmaceutical Holdings Co., Ltd.

Developing ophthalmic drugs and devices to preserve and restore vision for patients globally.

4596 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目7番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kubota Pharmaceutical Holdings Co., Ltd. is a holding company dedicated to developing and commercializing a diverse portfolio of drugs and devices to address sight-threatening ophthalmic diseases. Operating through its subsidiary, Kubota Vision Inc., the company's mission is to find cures for blindness and to preserve and restore vision for patients globally. Its pipeline includes pharmaceutical candidates and innovative medical devices, such as the "Kubota Glass®" wearable technology. The company focuses on translating scientific innovation into tangible therapeutic solutions through research, development, and global commercialization partnerships.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Kubota Pharmaceutical Holdings Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:30
Regulatory News Service
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第11期(2025/01/01-2025/12/31)
Japanese 230.5 KB
2025-07-31 08:37
Regulatory News Service
訂正臨時報告書
Japanese 35.5 KB
2025-07-16 08:30
Regulatory News Service
臨時報告書
Japanese 40.1 KB
2025-06-30 08:37
Regulatory News Service
訂正臨時報告書
Japanese 28.6 KB
2025-06-20 08:30
Regulatory News Service
臨時報告書
Japanese 27.5 KB
2025-04-21 08:30
Regulatory News Service
臨時報告書
Japanese 23.8 KB
2025-03-28 08:10
Regulatory News Service
確認書
Japanese 8.4 KB
2025-03-28 08:09
Annual Report
有価証券報告書-第10期(2024/01/01-2024/12/31)
Japanese 945.2 KB
2025-03-28 08:09
Regulatory News Service
内部統制報告書-第10期(2024/01/01-2024/12/31)
Japanese 22.6 KB
2024-08-20 08:11
Prospectus
有価証券届出書(組込方式)
Japanese 231.3 KB
2024-08-14 08:03
Regulatory News Service
確認書
Japanese 8.5 KB
2024-08-14 08:02
Interim Report
半期報告書-第10期(2024/01/01-2024/12/31)
Japanese 208.9 KB
2024-05-14 08:01
Regulatory News Service
確認書
Japanese 8.3 KB
2024-05-14 08:00
Quarterly Report
四半期報告書-第10期第1四半期(2024/01/01-2024/03/31)
Japanese 190.7 KB

Automate Your Workflow. Get a real-time feed of all Kubota Pharmaceutical Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Kubota Pharmaceutical Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.